Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology-Reference-Cited by-同舟云学术

Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

Published:2024-03 Issue:2 Volume:22 Page:117-135
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Abu-Rustum Nadeem R.¹,Yashar Catheryn M.²,Arend Rebecca³,Barber Emma⁴,Bradley Kristin⁵,Brooks Rebecca⁶,Campos Susana M.⁷,Chino Junzo⁸,Chon Hye Sook⁹,Crispens Marta Ann¹⁰,Damast Shari¹¹,Fisher Christine M.¹²,Frederick Peter¹³,Gaffney David K.¹⁴,Gaillard Stephanie¹⁵,Giuntoli Robert¹⁶,Glaser Scott¹⁷,Holmes Jordan¹⁸,Howitt Brooke E.¹⁹,Kendra Kari²⁰,Lea Jayanthi²¹,Lee Nita²²,Mantia-Smaldone Gina²³,Mariani Andrea²⁴,Mutch David²⁵,Nagel Christa²⁰,Nekhlyudov Larissa⁷,Podoll Mirna¹⁰,Rodabaugh Kerry²⁶,Salani Ritu²⁷,Schorge John²⁸,Siedel Jean²⁹,Sisodia Rachel³⁰,Soliman Pamela³¹,Ueda Stefanie³²,Urban Renata³³,Wethington Stephanie L.¹⁵,Wyse Emily³⁴,Zanotti Kristine³⁵,McMillian Nicole³⁶,Espinosa Sara³⁶

Affiliation:

1. Memorial Sloan Kettering Cancer Center

2. UC San Diego Moores Cancer Center

3. O’Neal Comprehensive Cancer Center at UAB

4. Robert H. Lurie Comprehensive Cancer Center of Northwestern University

5. University of Wisconsin Carbone Cancer Center

6. UC Davis Comprehensive Cancer Center

7. Dana-Farber/Brigham and Women’s Cancer Center

8. Duke Cancer Institute

9. Moffitt Cancer Center

10. Vanderbilt-Ingram Cancer Center

11. Yale Cancer Center/Smilow Cancer Hospital

12. University of Colorado Cancer Center

13. Roswell Park Comprehensive Cancer Center

14. Huntsman Cancer Institute at the University of Utah

15. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

16. Abramson Cancer Center at the University of Pennsylvania

17. City of Hope National Medical Center

18. Indiana University Melvin and Bren Simon Comprehensive Cancer Center

19. Stanford Cancer Institute

20. The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

21. UT Southwestern Simmons Comprehensive Cancer Center

22. The UChicago Medicine Comprehensive Cancer Center

23. Fox Chase Cancer Center

24. Mayo Clinic Comprehensive Cancer Center

25. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

26. Fred & Pamela Buffett Cancer Center

27. UCLA Jonsson Comprehensive Cancer Center

28. St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center

29. University of Michigan Rogel Cancer Center

30. Mass General Cancer Center

31. The University of Texas MD Anderson Cancer Center

32. UCSF Helen Diller Family Comprehensive Cancer Center

33. Fred Hutchinson Cancer Center

34. Patient Advocate

35. Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

36. National Comprehensive Cancer Network

Abstract

Vulvar cancer is annually diagnosed in an estimated 6,470 individuals and the vast majority are histologically squamous cell carcinomas. Vulvar cancer accounts for 5% to 8% of gynecologic malignancies. Known risk factors for vulvar cancer include increasing age, infection with human papillomavirus, cigarette smoking, inflammatory conditions affecting the vulva, and immunodeficiency. Most vulvar neoplasias are diagnosed at early stages. Rarer histologies exist and include melanoma, extramammary Paget’s disease, Bartholin gland adenocarcinoma, verrucous carcinoma, basal cell carcinoma, and sarcoma. This manuscript discusses recommendations outlined in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for treatments, surveillance, systemic therapy options, and gynecologic survivorship.

Publisher

Harborside Press, LLC

Link

https://jnccn.org/downloadpdf/journals/jnccn/22/2/article-p117.xml

Reference130 articles.

1. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease;Farias-Eisner R,1994

2. Surgical interventions for early squamous cell carcinoma of the vulva;Ansink A,2000

3. Individualization of treatment for stage I squamous cell vulvar carcinoma;Hacker NF,1984

4. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy;Burke TW,1995

5. Conservative management of early vulvar cancer;Hacker NF,1993

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment outcomes of vulvar and vaginal melanoma at an NCCN institution between 1993 and 2021;Gynecologic Oncology Reports;2024-10

2. Value of surgical lymph node assessment for patients with vulvar melanoma;European Journal of Cancer;2024-10

3. Incidence of postoperative venous thromboembolism in patients with vulvar carcinoma undergoing vulvectomy with or without lymphadenectomy;Gynecologic Oncology;2024-08

4. Rare phalanges soft tissue and bony metastasis in vulvar squamous cell carcinoma: Case report;Gynecologic Oncology Reports;2024-08

5. Vulvar cancer. The contribution of radiotherapy to the treatment of the disease;Siberian journal of oncology;2024-07-07